DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype

Abstract

Human NADPH-cytochrome P450 oxidoreductase (POR) gene mutations are associated with severe skeletal deformities and disordered steroidogenesis. The human POR mutation A287P presents with disordered sexual development and skeletal malformations. Difficult recombinant expression and purification of this POR mutant suggested that the protein was less stable than WT. The activities of cytochrome P450 17A1, 19A1, and 21A2, critical in steroidogenesis, were similar using our purified, full-length, unmodified A287P or WT POR, as were those of several xenobiotic-metabolizing cytochromes P450, indicating that the A287P protein is functionally competent in vitro, despite its functionally deficient phenotypic behavior in vivo. Differential scanning calorimetry and limited trypsinolysis studies revealed a relatively unstable A287P compared with WT protein, leading to the hypothesis that the syndrome observed in vivo results from altered POR protein stability. The crystal structures of the soluble domains of WT and A287P reveal only subtle differences between them, but these differences are consistent with the differential scanning calorimetry results as well as the differential susceptibility of A287P and WT observed with trypsinolysis. The relative in vivo stabilities of WT and A287P proteins were also examined in an osteoblast cell line by treatment with cycloheximide, a protein synthesis inhibitor, showing that the level ofmore » A287P protein post-inhibition is lower than WT and suggesting that A287P may be degraded at a higher rate. Overall, current studies demonstrate that, unlike previously described mutations, A287P causes POR deficiency disorder due to conformational instability leading to proteolytic susceptibility in vivo, rather than through an inherent flavin-binding defect.« less

Authors:
 [1];  [1];  [2];  [2];  [3];  [3];  [4];  [1];  [5];  [6];  [1];  [1];  [1]
  1. Univ. of Texas Health Science Center, San Antonio, TX (United States)
  2. Medical College of Wisconsin, Milwaukee, WI (United States)
  3. Univ. Nova de Lisboa (Portugal)
  4. Univ. of Michigan, Ann Arbor, MI (United States)
  5. State Univ. of New York Upstate Medical Univ., Syracuse, NY (United States)
  6. Charles Univ. in Prague (Czech Republic); General Univ. Hospital (Czech Republic)
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
National Institutes of Health (NIH); Fundação para a Ciência e a Tecnologia (FCT)
OSTI Identifier:
1328798
Grant/Contract Number:  
GM081568; GM097031; PTDC/SAU-GMG/71911/2006; UID/BIM/00009/ 2013; GM086596; GM086893; UNCE 204011; PRVOUK P24/LF1/3; RVO-VFN 64165/2012
Resource Type:
Accepted Manuscript
Journal Name:
Journal of Biological Chemistry
Additional Journal Information:
Journal Volume: 291; Journal Issue: 39; Journal ID: ISSN 0021-9258
Publisher:
American Society for Biochemistry and Molecular Biology
Country of Publication:
United States
Language:
ENGLISH
Subject:
59 BASIC BIOLOGICAL SCIENCES; 37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY; cytochrome P450; flavoprotein; membrane protein; protein crystallization; protein stability; reductase; POR deficiency; cytochrome P450 oxidoreductase; diflavin oxidoreductase

Citation Formats

McCammon, Karen M., Panda, Satya P., Xia, Chuanwu, Kim, Jung-Ja P., Moutinho, Daniela, Kranendonk, Michel, Auchus, Richard J., Lafer, Eileen M., Ghosh, Debashis, Martasek, Pavel, Kar, Rekha, Masters, Bettie Sue, and Roman, Linda J. Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype. United States: N. p., 2016. Web. doi:10.1074/jbc.M116.716019.
McCammon, Karen M., Panda, Satya P., Xia, Chuanwu, Kim, Jung-Ja P., Moutinho, Daniela, Kranendonk, Michel, Auchus, Richard J., Lafer, Eileen M., Ghosh, Debashis, Martasek, Pavel, Kar, Rekha, Masters, Bettie Sue, & Roman, Linda J. Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype. United States. https://doi.org/10.1074/jbc.M116.716019
McCammon, Karen M., Panda, Satya P., Xia, Chuanwu, Kim, Jung-Ja P., Moutinho, Daniela, Kranendonk, Michel, Auchus, Richard J., Lafer, Eileen M., Ghosh, Debashis, Martasek, Pavel, Kar, Rekha, Masters, Bettie Sue, and Roman, Linda J. Fri . "Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype". United States. https://doi.org/10.1074/jbc.M116.716019. https://www.osti.gov/servlets/purl/1328798.
@article{osti_1328798,
title = {Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype},
author = {McCammon, Karen M. and Panda, Satya P. and Xia, Chuanwu and Kim, Jung-Ja P. and Moutinho, Daniela and Kranendonk, Michel and Auchus, Richard J. and Lafer, Eileen M. and Ghosh, Debashis and Martasek, Pavel and Kar, Rekha and Masters, Bettie Sue and Roman, Linda J.},
abstractNote = {Human NADPH-cytochrome P450 oxidoreductase (POR) gene mutations are associated with severe skeletal deformities and disordered steroidogenesis. The human POR mutation A287P presents with disordered sexual development and skeletal malformations. Difficult recombinant expression and purification of this POR mutant suggested that the protein was less stable than WT. The activities of cytochrome P450 17A1, 19A1, and 21A2, critical in steroidogenesis, were similar using our purified, full-length, unmodified A287P or WT POR, as were those of several xenobiotic-metabolizing cytochromes P450, indicating that the A287P protein is functionally competent in vitro, despite its functionally deficient phenotypic behavior in vivo. Differential scanning calorimetry and limited trypsinolysis studies revealed a relatively unstable A287P compared with WT protein, leading to the hypothesis that the syndrome observed in vivo results from altered POR protein stability. The crystal structures of the soluble domains of WT and A287P reveal only subtle differences between them, but these differences are consistent with the differential scanning calorimetry results as well as the differential susceptibility of A287P and WT observed with trypsinolysis. The relative in vivo stabilities of WT and A287P proteins were also examined in an osteoblast cell line by treatment with cycloheximide, a protein synthesis inhibitor, showing that the level of A287P protein post-inhibition is lower than WT and suggesting that A287P may be degraded at a higher rate. Overall, current studies demonstrate that, unlike previously described mutations, A287P causes POR deficiency disorder due to conformational instability leading to proteolytic susceptibility in vivo, rather than through an inherent flavin-binding defect.},
doi = {10.1074/jbc.M116.716019},
journal = {Journal of Biological Chemistry},
number = 39,
volume = 291,
place = {United States},
year = {Fri Aug 05 00:00:00 EDT 2016},
month = {Fri Aug 05 00:00:00 EDT 2016}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 14 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Mutation of regulatory serines of rat tyrosine hydroxylase to glutamate: effects on enzyme stability and activity
journal, February 2005

  • Royo, Montserrat; Fitzpatrick, Paul F.; Daubner, S. Colette
  • Archives of Biochemistry and Biophysics, Vol. 434, Issue 2
  • DOI: 10.1016/j.abb.2004.11.007

Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley–Bixler syndrome variants of cytochrome P450 oxidoreductase
journal, July 2008

  • Kranendonk, Michel; Marohnic, Christopher C.; Panda, Satya P.
  • Archives of Biochemistry and Biophysics, Vol. 475, Issue 2
  • DOI: 10.1016/j.abb.2008.04.014

Stopped-Flow Kinetic Studies of Flavin Reduction in Human Cytochrome P450 Reductase and Its Component Domains
journal, February 2001

  • Gutierrez, Aldo; Lian, Lu-Yun; Wolf, C. Roland
  • Biochemistry, Vol. 40, Issue 7
  • DOI: 10.1021/bi001719m

Overview of the CCP 4 suite and current developments
journal, March 2011

  • Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
  • DOI: 10.1107/S0907444910045749

Genetic variations in NADPH-CYP450 oxidoreductase in a Czech Slavic cohort
journal, March 2015

  • Tomková, Mária; Panda, Satya Prakash; Šeda, Ondřej
  • Pharmacogenomics, Vol. 16, Issue 3
  • DOI: 10.2217/pgs.14.169

Restoration of mutant cytochrome P450 reductase activity by external flavin
journal, June 2010

  • Nicolo, Catherine; Flück, Christa E.; Mullis, Primus E.
  • Molecular and Cellular Endocrinology, Vol. 321, Issue 2
  • DOI: 10.1016/j.mce.2010.02.024

Altered Human CYP3A4 Activity Caused by Antley-Bixler Syndrome-Related Variants of NADPH-Cytochrome P450 Oxidoreductase Measured in a Robust In Vitro System
journal, January 2012

  • Moutinho, Daniela; Marohnic, Christopher C.; Panda, Satya P.
  • Drug Metabolism and Disposition, Vol. 40, Issue 4
  • DOI: 10.1124/dmd.111.042820

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
journal, September 1998

  • Brünger, A. T.; Adams, P. D.; Clore, G. M.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 54, Issue 5
  • DOI: 10.1107/S0907444998003254

Inactivation of the Hepatic Cytochrome P450 System by Conditional Deletion of Hepatic Cytochrome P450 Reductase
journal, February 2003

  • Henderson, Colin J.; Otto, Diana M. E.; Carrie, Dianne
  • Journal of Biological Chemistry, Vol. 278, Issue 15
  • DOI: 10.1074/jbc.M212087200

Structural basis for androgen specificity and oestrogen synthesis in human aromatase
journal, January 2009

  • Ghosh, Debashis; Griswold, Jennifer; Erman, Mary
  • Nature, Vol. 457, Issue 7226
  • DOI: 10.1038/nature07614

Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency
journal, February 2012

  • Krone, Nils; Reisch, Nicole; Idkowiak, Jan
  • The Journal of Clinical Endocrinology & Metabolism, Vol. 97, Issue 2
  • DOI: 10.1210/jc.2011-0640

Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism
journal, October 2010

  • Flück, Christa E.; Mullis, Primus E.; Pandey, Amit V.
  • Biochemical and Biophysical Research Communications, Vol. 401, Issue 1
  • DOI: 10.1016/j.bbrc.2010.09.035

NADPH P450 oxidoreductase: Structure, function, and pathology of diseases
journal, May 2013


POR R457H is a global founder mutation causing Antley–Bixler syndrome with autosomal recessive trait
journal, January 2006

  • Adachi, Masanori; Asakura, Yumi; Matsuo, Mari
  • American Journal of Medical Genetics Part A, Vol. 140A, Issue 6
  • DOI: 10.1002/ajmg.a.31112

Diminished FAD Binding in the Y459H and V492E Antley-Bixler Syndrome Mutants of Human Cytochrome P450 Reductase
journal, September 2006

  • Marohnic, Christopher C.; Panda, Satya P.; Martásek, Pavel
  • Journal of Biological Chemistry, Vol. 281, Issue 47
  • DOI: 10.1074/jbc.M607095200

Suppression of human cytochrome P450 aromatase activity by monoclonal and recombinant antibody fragments and identification of a stable antigenic complex
journal, March 2004

  • Lala, Puloma; Higashiyama, Tadayoshi; Erman, Mary
  • The Journal of Steroid Biochemistry and Molecular Biology, Vol. 88, Issue 3
  • DOI: 10.1016/j.jsbmb.2003.12.010

Human Cytochrome P450 21A2, the Major Steroid 21-Hydroxylase: STRUCTURE OF THE ENZYME·PROGESTERONE SUBSTRATE COMPLEX AND RATE-LIMITING C–H BOND CLEAVAGE
journal, April 2015

  • Pallan, Pradeep S.; Wang, Chunxue; Lei, Li
  • Journal of Biological Chemistry, Vol. 290, Issue 21
  • DOI: 10.1074/jbc.M115.646307

Genetics of P450 oxidoreductase: Sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations
journal, January 2008

  • Huang, N.; Agrawal, V.; Giacomini, K. M.
  • Proceedings of the National Academy of Sciences, Vol. 105, Issue 5
  • DOI: 10.1073/pnas.0711621105

Cytochrome P450 Oxidoreductase Gene Mutations and Antley-Bixler Syndrome with Abnormal Genitalia and/or Impaired Steroidogenesis: Molecular and Clinical Studies in 10 Patients
journal, January 2005

  • Fukami, Maki; Horikawa, Reiko; Nagai, Toshiro
  • The Journal of Clinical Endocrinology & Metabolism, Vol. 90, Issue 1
  • DOI: 10.1210/jc.2004-0810

Local fluctuations vs. global unfolding of proteins investigated by limited proteolysis
journal, January 2005

  • Arnold, Ulrich; Köditz, Jens; Markert, Yvonne
  • Biocatalysis and Biotransformation, Vol. 23, Issue 3-4
  • DOI: 10.1080/10242420500183287

Riboflavin-responsive epilepsy in a patient with SER209 variant form of short-chain acyl-CoA dehydrogenase
journal, March 1995

  • Kmoch, S.; Zeman, J.; Hrebíček, M.
  • Journal of Inherited Metabolic Disease, Vol. 18, Issue 2
  • DOI: 10.1007/BF00711774

X-ray structure of human aromatase reveals an androgen-specific active site
journal, February 2010

  • Ghosh, Debashis; Griswold, Jennifer; Erman, Mary
  • The Journal of Steroid Biochemistry and Molecular Biology, Vol. 118, Issue 4-5
  • DOI: 10.1016/j.jsbmb.2009.09.012

Association of Multiple Developmental Defects and Embryonic Lethality with Loss of Microsomal NADPH-Cytochrome P450 Oxidoreductase
journal, December 2001

  • Shen, Anna L.; O'Leary, Kathleen A.; Kasper, Charles B.
  • Journal of Biological Chemistry, Vol. 277, Issue 8
  • DOI: 10.1074/jbc.M111408200

Structure of the open conformation of a functional chimeric NADPH cytochrome P450 reductase
journal, May 2009

  • Aigrain, Louise; Pompon, Denis; Moréra, Solange
  • EMBO reports, Vol. 10, Issue 7
  • DOI: 10.1038/embor.2009.82

Epoxidation Activities of Human Cytochromes P450c17 and P450c21
journal, November 2014

  • Yoshimoto, Francis K.; Peng, Hwei-Ming; Zhang, Haoming
  • Biochemistry, Vol. 53, Issue 48
  • DOI: 10.1021/bi5011865

Human Cytochrome P450c17: Single Step Purification and Phosphorylation of Serine 258 by Protein Kinase A
journal, February 2010

  • Wang, Yue-Hao; Tee, Meng Kian; Miller, Walter L.
  • Endocrinology, Vol. 151, Issue 4
  • DOI: 10.1210/en.2009-1247

Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158

Functional Expression and Comparative Characterization of Nine Murine Cytochromes P450 by Fluorescent Inhibition Screening
journal, April 2008

  • McLaughlin, Lesley A.; Dickmann, Leslie J.; Wolf, C. Roland
  • Drug Metabolism and Disposition, Vol. 36, Issue 7
  • DOI: 10.1124/dmd.108.021261

Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study
journal, June 2004


Human Cytochrome P450 Oxidoreductase Deficiency Caused by the Y181D Mutation: Molecular Consequences and Rescue of Defect
journal, November 2009

  • Marohnic, Christopher C.; Panda, Satya P.; McCammon, Karen
  • Drug Metabolism and Disposition, Vol. 38, Issue 2
  • DOI: 10.1124/dmd.109.030445

Riboflavin therapy
journal, December 1999


Diversity and Function of Mutations in P450 Oxidoreductase in Patients with Antley-Bixler Syndrome and Disordered Steroidogenesis
journal, May 2005

  • Huang, Ningwu; Pandey, Amit V.; Agrawal, Vishal
  • The American Journal of Human Genetics, Vol. 76, Issue 5
  • DOI: 10.1086/429417

Identification of six novel P450 oxidoreductase missense variants in Ashkenazi and Moroccan Jewish populations
journal, April 2012

  • Tomková, Mária; Marohnic, Christopher C.; Gurwitz, David
  • Pharmacogenomics, Vol. 13, Issue 5
  • DOI: 10.2217/pgs.12.21

Measurement of Membrane-Bound Human Heme Oxygenase-1 Activity Using a Chemically Defined Assay System
journal, January 2009

  • Huber, Warren J.; Marohnic, Christopher C.; Peters, Michelle
  • Drug Metabolism and Disposition, Vol. 37, Issue 4
  • DOI: 10.1124/dmd.108.025023

Structure and Function of an NADPH-Cytochrome P450 Oxidoreductase in an Open Conformation Capable of Reducing Cytochrome P450
journal, January 2009

  • Hamdane, Djemel; Xia, Chuanwu; Im, Sang-Choul
  • Journal of Biological Chemistry, Vol. 284, Issue 17
  • DOI: 10.1074/jbc.M807868200

NMRPipe: A multidimensional spectral processing system based on UNIX pipes
journal, November 1995

  • Delaglio, Frank; Grzesiek, Stephan; Vuister, GeertenW.
  • Journal of Biomolecular NMR, Vol. 6, Issue 3
  • DOI: 10.1007/BF00197809

Three-dimensional structure of NADPH-cytochrome P450 reductase: Prototype for FMN- and FAD-containing enzymes
journal, August 1997

  • Wang, M.; Roberts, D. L.; Paschke, R.
  • Proceedings of the National Academy of Sciences, Vol. 94, Issue 16
  • DOI: 10.1073/pnas.94.16.8411

Molecular replacement with MOLREP
journal, December 2009

  • Vagin, Alexei; Teplyakov, Alexei
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 1
  • DOI: 10.1107/S0907444909042589

Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization
journal, September 2011

  • Marohnic, Christopher C.; Huber III, Warren J.; Patrick Connick, J.
  • Archives of Biochemistry and Biophysics, Vol. 513, Issue 1
  • DOI: 10.1016/j.abb.2011.06.008

Coupled Motions Direct Electrons along Human Microsomal P450 Chains
journal, December 2011


Folding screening assayed by proteolysis: application to various cystine deletion mutants of vascular endothelial growth factor
journal, March 2001

  • Heiring, Christoph; Muller, Yves A.
  • Protein Engineering, Design and Selection, Vol. 14, Issue 3
  • DOI: 10.1093/protein/14.3.183

Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
journal, February 2004

  • Flück, Christa E.; Tajima, Toshihro; Pandey, Amit V.
  • Nature Genetics, Vol. 36, Issue 3
  • DOI: 10.1038/ng1300

Analytical and production seeding techniques
journal, August 1990


Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome
journal, January 2004

  • Adachi, Masanori; Tachibana, Katsuhiko; Asakura, Yumi
  • American Journal of Medical Genetics, Vol. 128A, Issue 4
  • DOI: 10.1002/ajmg.a.30169

Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency
journal, August 2011

  • Xia, C.; Panda, S. P.; Marohnic, C. C.
  • Proceedings of the National Academy of Sciences, Vol. 108, Issue 33
  • DOI: 10.1073/pnas.1106632108

High‐level expression of functional human cytochrome P450 1A2 in Escherichia coli
journal, January 1992

  • Fisher, Charles W.; Caudle, Deborah L.; Martin‐Wixtrom, Cheryl
  • The FASEB Journal, Vol. 6, Issue 2
  • DOI: 10.1096/fasebj.6.2.1537466

NADPH–Cytochrome P450 Oxidoreductase: Roles in Physiology, Pharmacology, and Toxicology
journal, October 2012

  • Riddick, David S.; Ding, Xinxin; Wolf, C. Roland
  • Drug Metabolism and Disposition, Vol. 41, Issue 1
  • DOI: 10.1124/dmd.112.048991

Immunochemical Evidence for an Association of Heme Oxygenase with the Microsomal Electron Transport System
journal, June 1972

  • Schacter, Brent A.; Nelson, Edward B.; Marver, Harvey S.
  • Journal of Biological Chemistry, Vol. 247, Issue 11
  • DOI: 10.1016/S0021-9258(19)45183-1

Solubilization and partial characterization of rat liver squalene epoxidase.
journal, February 1975


Probing protein structure by limited proteolysis.
journal, June 2004

  • Fontana, Angelo; De Laureto, Patrizia Polverino; Spolaore, Barbara
  • Acta Biochimica Polonica, Vol. 51, Issue 2
  • DOI: 10.18388/abp.2004_3573

[20] Processing of X-ray diffraction data collected in oscillation mode
book, January 1997


Conformational exchange in the potassium channel blocker ShK
journal, December 2019


Multi-functionality of a tryptophan residue conserved in substrate-binding groove of GH19 chitinases
journal, January 2021


Overview of the CCP4 suite and current developments.
text, January 2011

  • Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.52322

Restoration of mutant cytochrome P450 reductase activity by external flavin
text, January 2010

  • Nicolo, Catherine; Flück, Christa E.; Mullis, Primus E.
  • Elsevier Ireland
  • DOI: 10.7892/boris.158

Works referencing / citing this record:

Lipid-exchange in nanodiscs discloses membrane boundaries of cytochrome-P450 reductase
journal, January 2018

  • Barnaba, Carlo; Ravula, Thirupathi; Medina-Meza, Ilce G.
  • Chemical Communications, Vol. 54, Issue 49
  • DOI: 10.1039/c8cc02003e

The Hinge Segment of Human NADPH-Cytochrome P450 Reductase in Conformational Switching: The Critical Role of Ionic Strength
journal, October 2017


Probing the Role of the Hinge Segment of Cytochrome P450 Oxidoreductase in the Interaction with Cytochrome P450
journal, December 2018

  • Campelo, Diana; Esteves, Francisco; Palma, Bernardo Brito
  • International Journal of Molecular Sciences, Vol. 19, Issue 12
  • DOI: 10.3390/ijms19123914

Accurate Determination of Human CPR Conformational Equilibrium by smFRET Using Dual Orthogonal Noncanonical Amino Acid Labeling
journal, January 2019

  • Quast, Robert B.; Fatemi, Fataneh; Kranendonk, Michel
  • ChemBioChem, Vol. 20, Issue 5
  • DOI: 10.1002/cbic.201800607